StonvexLoading…
StonvexStonvexStonvexCore line items from PTC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $617.97M | $1.46B | $685.83M | $2.74B | $1.85B |
Operating Income | Not available | $516.93M | $221.13M | $982.38M | $548.82M |
Net Income | Not available | $757.24M | $166.52M | $734.00M | $386.20M |
EPS (Diluted) | $1.61 | $6.35 | $1.39 | $6.08 | $3.20 |
Total Assets | Not available | $6.54B | $6.43B | $6.62B | $6.23B |
Total Liabilities | Not available | $2.68B | $2.58B | $2.79B | $2.72B |
Cash & Equivalents | Not available | $439.11M | $209.74M | $184.41M | $199.32M |
Free Cash Flow OCF − CapEx | Not available | $585.65M | $267.40M | $856.69M | $756.20M |
Shares Outstanding | Not available | 115.50M | 118.89M | 119.54M | 119.79M |